参考文献/References:
[1] World Health Organization. Global report on diabetes[J].World Health Organization,2016.
[2] Filadi R, Theurey P, Pizzo P. The endoplasmic reticulum-mitochondria coupling in health and disease:molecules, functions and significance[J].Cell
Calcium,2017,62:1-15.DOI:10.1016/j.ceca.2017.01.003.
[3] Marchi S,Patergnani S,Pinton P.The endoplasmic reticulum-mitochondria connection:one touch, multiple functions[J].Biochim Biophys Acta,
2014,1837(4):461-469.DOI:10.1016/j.bbabio.2013.10.015.
[4] Basso V,Marchesan E,Peggion C,et al.Regulation of ER-mitochondria contacts by Parkin via Mfn2[J].Pharmacol Res,2018,138:43-
56.DOI:10.1016/j.phrs.2018.09.006.
[5] Janikiewicz J, Szymański J, Malinska D,et al.Mitochondria-associated membranes in aging and senescence:structure, function, and dynamics[J].Cell
Death Dis,2018,9(3):1-12.DOI:10.1038/s41419-017-0105-5.
[6] Kerkhofs M, Bultynck G, Vervliet T,et al. Therapeutic implications of novel peptides targeting ER-mitochondria Ca(2+)-flux systems[J].Drug Discov
Today,2019,24(5):1092-1103.DOI:10.1016/j.drudis.2019.03.020.
[7] Rieusset J, Fauconnier J, Paillard M, et al.Disruption of calcium transferfrom ER to mitochondria links alterations of mitochondria-associated ER
membrane integrity to hepatic insulin resistance[J].Diabetologia,2016,59(3):614-623.DOI:10.1007/s00125-015-3829-8.
[8] Bravo R, Vicencio JM, Parra V, et al.Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases
of ER stress[J].J Cell Sci,2011,124(Pt 13):2143-2152.DOI:10.1242/jcs.080762.
[9] Verfaillie T, Rubio N, Garg AD, et al.PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress
[J].Cell Death Differ, 2012,19(11):1880-1891.DOI:10.1038/cdd.2012.74.
[10] Gomez-Suaga P. The ER-mitochondria tethering complex VAPB-PTPIP51 regulates autophagy[J].Curr Biol,2017:27(3):371-
385.DOI:10.1016/j.cub.2016.12.038.
[11] Theurey P,Rieusset J. Mitochondria-associated membranes response tonutrient availability and role in metabolic diseases[J].Trends Endocrinol
Metab,2017,28(1):32-45.DOI:10.1016/j.tem.2016.09.002.
[12] Theurey P. Mitochondria-associated endoplasmic reticulum membrane sallow adaptation of mitochondrial metabolism to glucose availability in the
liver[J].J Mol Cell Biol,2016,8(2):129-143.DOI:10.1093/jmcb/mjw004.
[13] Tubbs E, Axelsson AS,Vial G, et al. Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose
production[J].Mol Cell Endocrinol,2018,461:205-214.DOI:10.1016/j.mce.2017.09.016.
[14] Tubbs E, Theurey P, Vial G, et al.Mitochondria-associated endoplasmic reticulum membrane(MAM)integrity is required for insulin signaling and is
implicated in hepatic insulin resistance[J].Diabetes,2014,63(10):3279-3294.DOI:10.2337/db13-1751.
[15] Shinjo S, Jiang S, Nameta M, et al. Disruption of the mitochondria-associated ER membrane(MAM)plays a central role in palmitic acid-induced
insulin resistance[J].Exp Cell Res,2017,359(1):86-93.DOI:10.1016/j.yexcr.2017.08.006.
[16] Rieusset J, Fauconnier J, Paillard M, et al. Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated
ER membrane integrity to hepatic insulin resistance[J].Diabetologia,2016,59(3):614-623.DOI:10.1007/s00125-015-3829-8.
[17] Gan KX, Wang C, Chen JH, et al.Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats[J].World J Gatroenterol,2013,19
(10):1572-1581.DOI:10.3748/wjg.v19.i10.1572.
[18] Contreras-Ferrat A,Lavandero S,Jaimovich E,et al.Calcium signaling in insulin action on striated muscle[J].Cell Calcium,2014,56(5):390-
396.DOI:10.1016/j.ceca.2014.08.012.
[19] Tubbs E, Chanon S, Robert M. Disruption of mitochondria-associated endoplasmic reticulum membrane(MAM)integrity contributes to muscle insulin
resistance in mice and humans[J]. Diabetes,2018,67(4):636-650.DOI:10.2337/db17-0316.
[20] Wang CH,Chen YF, Wu CY,et al.Cisd2 modulates the differentiation and functioning of adipocytes by regulating intracellular Ca2+
homeostasis[J].Mol Genet, 2014, 23(18):4770-4785.DOI:10.1093/hmg/ddu193.
[21] Arruda AP,Pers BM, Parlakgül G, et al.Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial
dysfunction in obesity[J].Nat Med,2014, 20(12):1427-1435.DOI:10.1038/nm.3735.
[22] Thoudam T, Ha CM, Leem J, et al. PDK4 augments ER-mitochondria contact to dampen skeletal muscle insulin signaling during obesity
[J].Diabetes,2019,68(3):571-586.DOI:10.2337/db18-0363.
[23] Rieusset J.Role of endoplasmic reticulum-mitochondria communication in type 2 diabetes[J].Adv Exp Med Biol,2017,997:171-186.DOI: 10.1007/978-981
-10-4567-7_13.
[24] Klec C, Madreiter-Sokolowski CT, Stryeck S, et al. Glycogen synthase kinase 3 beta controls presenilin-1-mediated endoplasmic reticulum
Ca2+ leak directed to mitochondria in pancreatic islets and beta-cells[J].Cell Physiol Biochem,2019,52(1):57-75.DOI: 10.33594/000000005.
[25] Rutter GA, Pinton P. Mitochondria-associated endoplasmic reticulum membranes in insulin signaling [J].Diabetes, 2014,63(10):3163-
3165.DOI:10.2337/db14-0812.
[26] hivolet C, Vial G, Cassel R,et al. Reduction of endoplasmic reticulum-mitochondria interactions in beta cells from patients with type 2 diabetes
[J].PLoS One,2017,12(7):e182027.DOI:10.1371/journal.pone.0182027.
[27] Dingreville F, Panthu B, Thivolet C,et al. Differential effect of glucose on ER-mitochondria Ca2+ exchange participates to insulin
secretion and to glucotoxicity-mediated dysfunction of β cells[J].Diabetes,2019,68(9):1778-1794.DOI: 10.2337/db18-1112.
[28] Rieusset J. The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis:an update[J].Cell Death
Disease,2018,9(3):1-12.DOI: 10.1038/s41419-018-0416-1.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(05):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]